Measurement of pulse wave velocity, augmentation index, and central pulse pressure in atrial fibrillation: a proof of concept study

Individualized weighing of the risk benefit of anticoagulation is recommended in patients with atrial fibrillation (AF) who have low established risk scores or, conversely, are at increased risk for bleeding. Parameters of arterial stiffness and wave reflection could improve risk stratification, but their use has not been evaluated in arrhythmia. We measured carotid-femoral pulse wave velocity (PWV), central augmentation index (AI), and central pulse pressure (CPP) using the SphygmoCor system in 34 patients (53 to 85  years; 25 males) with AF before and after elective electrical cardioversion.

Source: Journal of the American Society of Hypertension - July 2, 2018 Category: Cardiology Authors: Rogier Caluw é, An S. De Vriese, Bruno Van Vlem, Francis Verbeke Tags: Research Article Source Type: research